tradingkey.logo

Pulmonx Corp <LUNG.OQ> expected to post a loss of 40 cents a share - Earnings Preview

ReutersJul 28, 2025 8:02 PM
  • Pulmonx Corp LUNG.OQ LUNG.O is expected to show a rise in quarterly revenue when it reports results on July 30 for the period ending June 30 2025

  • The Redwood City California-based company is expected to report a 12.9% increase in revenue to $23.468 million from $20.78 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Pulmonx Corp is for a loss of 40 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Pulmonx Corp is $13.50, about 75.3% above its last closing price of $3.34

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Mar. 31 2025

-0.39

-0.40

-0.36

Beat

10

Dec. 31 2025

-0.44

-0.45

-0.33

Beat

26.3

Sep. 30 2024

-0.45

-0.45

-0.36

Beat

19.7​

Jun. 30 2024

-0.42

-0.43

-0.35

Beat

17.7

​​Mar. 31 2024

-0.45

-0.46

-0.36

Beat

22

Dec. 31 2023

-0.38

-0.41

-0.36

Beat

11.6​

Sep. 30 2023

-0.42

-0.43

-0.39

Beat

8.8

Jun. 30 2023

-0.44

-0.44

-0.43

Beat

1.6

This summary was machine generated July 28 at 20:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI